LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 23 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,349,000 | -7.5% | 2,000,000 | 0.0% | 0.58% | -14.5% |
| Q4 2018 | $3,619,000 | -50.6% | 2,000,000 | 0.0% | 0.68% | -51.6% |
| Q3 2018 | $7,326,000 | -33.4% | 2,000,000 | -50.0% | 1.40% | -40.2% |
| Q2 2018 | $11,007,000 | +25.7% | 4,000,000 | 0.0% | 2.34% | +14.2% |
| Q1 2018 | $8,758,000 | +19.7% | 4,000,000 | 0.0% | 2.05% | +13.5% |
| Q4 2017 | $7,314,000 | -0.1% | 4,000,000 | 0.0% | 1.80% | -27.6% |
| Q3 2017 | $7,320,000 | – | 4,000,000 | – | 2.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mint Tower Capital Management B.V. | 10,000,000 | $14,917,000 | 3.39% |
| Opera Trading Capital | 5,700,000 | $8,490,000 | 2.38% |
| TFG Asset Management GP Ltd | 8,100,000 | $12,093,000 | 2.27% |
| CQS Cayman LP | 18,000,000 | $26,872,000 | 2.04% |
| BASSO CAPITAL MANAGEMENT, L.P. | 6,470,000 | $9,632,000 | 1.43% |
| Myriad Asset Management Ltd. | 9,416,000 | $14,061,000 | 1.04% |
| CAMDEN ASSET MANAGEMENT L P /CA | 22,025,000 | $32,817,000 | 0.85% |
| ANGELO GORDON & CO., L.P. | 7,000,000 | $10,430,000 | 0.64% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 25,000,000 | $37,301,000 | 0.54% |
| CSS LLC/IL | 5,105,000 | $7,617,000 | 0.46% |